Carsten Müller

  • Autor

Carsten Müller has been working as a financial journalist for over 20 years. Born in Berlin, he began his professional career as an editor in the Telebörse editorial staff of n-tv. He then worked as a freelance journalist for renowned stock letter publishers in German-speaking countries and is still active today as a publisher or editor-in-chief of numerous stock market publications, including special issues on equities and global bonds. In its investment approaches, it is strongly oriented fundamentally, without, of course, renouncing to time indicators. In particular, it wants to show its readers the opportunities for long-term asset accumulation.


Alle Artikel
DatumArtikelLeser
30. Jul
Nordex: How Dangerous Is It Now?+Is it possible that Nordex is running out of time now? At the beginning of the month, the wind turbine manufacturer’s share was still able to post strong gains. This was because it was able to present a full order book to the market. However, this steep step was quickly lost after bad news came […]
Weiterlesen
98
23. Apr
Osram Light: Cheap enough?+At the beginning of the second quarter, Osram, the lighting specialist, is still in a gloomy mood. Which is mainly homemade. In recent months, the company has been providing bad news that more and more investors and analysts have turned their backs on it. Osram only provides negative news! The three profit warnings in the […]
Weiterlesen
56
17. Apr
Nordex: A new tailwind for the share?+It will be less than a month before the wind turbine manufacturer Nordex presents its figures for the first quarter of the current fiscal year. But the company is already looking good and gathering evidence that the annual report could convince the market. On Wednesday, for example, Nordex announced that new orders with a total […]
Weiterlesen
56
17. Apr
Wirecard: How dangerous is this message?+At the German payment service provider Wirecard, everything is looking forward to tomorrow. Because then the previous short selling prohibition of the BaFin expires officially. But only after the market closes, which means that it could only be really exciting after the long Easter weekend. In addition, there is still the suspicion that the BaFin […]
Weiterlesen
56
17. Apr
Netflix: What matters now!+The market had eagerly awaited Netflix’s figures for the first quarter. Just a few days ago, entertainment giant Disney announced its intention to launch a new streaming service. This means that Netflix is not only dealing with previous rivals such as Amazon and Hulu, but in future also with Disney and Apple, who are also […]
Weiterlesen
92
16. Apr
Freenet: No more Switzerland adventures?+The coming weeks could be extremely exciting for Freenet and its shareholders. Because everything is heading in the direction of a directional decision in the previous investment in the Swiss mobile communications company Sunrise. As is well known, this company intends to take over the cable network operator UPC for around CHF 6.3 billion. It […]
Weiterlesen
56
16. Apr
Biofrontera: What to think of this offer?+The biopharmaceutical company Biofrontera is currently performing optimally. At the beginning of the week, the company reported preliminary sales figures for the first quarter of 2019, with a further significant increase of approx. 46% to 6.8 million euros. As expected, Biofrontera makes up the bulk of its business in the USA. Biofrontera with strong sales […]
Weiterlesen
92
16. Apr
Nokia: This could still hurt!+The new stock exchange week started off as anything but pleasant for Finnish mobile phone supplier Nokia. Two topics spoiled the mood of investors, which could grow into a solid correction. Daimler complains about Nokia! On the one hand Nokia has trouble with the car manufacturer Daimler. The latter has complained to the EU Commission […]
Weiterlesen
56
15. Apr
Evotec: How from the picture book?+Last week the Evotec share showed some nerves. Which is not surprising. After all, the biotech value reached a new all-time high of 25.45 euros despite the already exorbitant evaluation. It is not surprising that short-term profit-taking can sometimes occur during such an event. However, investors must of course ask themselves whether this could be […]
Weiterlesen
80
15. Apr
Morphosys: It’s getting dangerous again!+It’s already a real disappointment. Although the industry environment is actually better than it has been for a long time, the German biotech value Morphosys is not really coming off the mark. Share performance in recent months has been a proverbial catastrophe. While the MDAX, in which Morphosys has been a member since 2018, has […]
Weiterlesen
56
15. Apr
Aixtron: That would be the bomb!+For days now there have been persistent rumors that the special machine manufacturer Aixtron could become the target of a takeover. As is well known, the company specializes in machines for semiconductor production. And this with a technology that is regarded as innovative in the market. The buying interests are queuing up? No wonder that […]
Weiterlesen
56
01. Apr
Osram: This could really hurt again.+Last week on the stock exchange was a catastrophe for lighting specialist Osram. After Osram lowered its forecast for the year, the stock collapsed by around 10 % last Thursday. Although she was able to recover slightly by the end of the week, this could possibly only be a breather. Because also in the new […]
Weiterlesen
80
11. Feb
Electronic Arts: Roller coaster with a good outcome!+For the American games manufacturer Electronic Arts, the presentation of the latest quarterly report caused considerable price turbulence. This was due in particular to the fact that the software manufacturer, which is particularly well-known for its shooter games such as “Battlefield” or sports gaming software such as “Madden”, reduced its sales forecast for the year […]
Weiterlesen
86
11. Feb
Fresenius: Is there another reset?+The last two trading days of the past week were also no walk in the park for the Fresenius health care group. After the share had recovered from its 12-month low of 38.28 euros at the beginning of December by an impressive 24% to 47.50 euros, an important chart test at this level was now […]
Weiterlesen
56